Liposomal Composition for Agricultural and Veterinary Applications

This inventive concept leverages the core technology of docetaxel liposomes to target pest cells, fungal infections, parasitic infections, and aquaculture diseases in agricultural and veterinary fields, offering a novel solution for these industries.

The original patent focused on developing docetaxel liposomes for cancer treatment, but its limitations in terms of targeting and delivery can be overcome by applying this technology to other industries. The new inventive concept addresses the need for effective solutions in agricultural pest control, veterinary medicine, and aquaculture.

The liposomal composition consists of docetaxel, Soya Phosphatidyl Choline, Sodium Cholesteryl Sulfate, and Sucrose, with specific weight percentages and pH adjustments. This composition is designed to target pest cells, fungal infections, parasitic infections, and aquaculture diseases, providing a targeted and efficient delivery system.

The new claims introduce a novel application of docetaxel liposomes in agricultural and veterinary fields, which is non-obvious compared to the original patent's focus on cancer treatment. The inventive step lies in adapting the liposomal composition to target specific cells and diseases in these industries.

Other embodiments of the inventive concept could include varying the weight percentages of the liposomal composition, adjusting the pH, or incorporating additional components to enhance targeting and delivery. These variations could be explored to further expand the scope of the inventive concept.

The inventive concept has significant commercial potential in the agricultural and veterinary industries, offering a novel solution for pest control, fungal infections, parasitic infections, and aquaculture diseases. The target market includes companies involved in agricultural pest control, veterinary medicine, and aquaculture, as well as research institutions exploring new applications for liposomal technology.